Literature DB >> 2430477

Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from schneiderian epithelium and distinct from olfactory neuroblastoma.

H F Frierson, S E Mills, R E Fechner, J B Taxy, P A Levine.   

Abstract

Eight cases of a highly aggressive undifferentiated carcinoma of the nasal cavity and paranasal sinuses are described. The patients, who ranged in age from 30-77 years, had multiple sinonasal symptoms, and each had involvement of the nasal cavity, maxillary antrum, and ethmoid sinus. Six tumors extended into the orbital bones, and five penetrated the cranial cavity. Five patients died of disease from 1 to 41 months after diagnosis (median: 4 months), and three are alive with tumor less than 1 year following diagnosis. Microscopically, the neoplasms formed nests, trabeculae, and sheets containing medium-sized cells with small to moderate amounts of eosinophilic cytoplasm. A high mitotic rate, tumor necrosis, and prominent vascular permeation were characteristic. Seven neoplasms were immunoreactive for cytokeratin, five for epithelial membrane antigen, and four for neuron-specific enolase. Ultrastructurally, occasional small desmosomes and rare membrane-bound, dense-core granules were observed. Sinonasal undifferentiated carcinoma is a distinctive clinicopathologic entity that must be distinguished from other, less aggressive sinonasal neoplasms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430477

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  46 in total

1.  [Sinonasal undifferentiated carcinoma. A rare and aggressive neoplasm of the nasal cavity and paranasal sinuses].

Authors:  O Reichel; S Ihrler; F Born; M Andratschke; G Rasp; H Hagedorn
Journal:  HNO       Date:  2006-05       Impact factor: 1.284

2.  Surgical pathology of the skull base: a 7-year experience.

Authors:  R Gandour-Edwards; P J Donald; J E Boggan
Journal:  Skull Base Surg       Date:  1998

3.  Sinonasal undifferentiated carcinoma: current trends in treatment.

Authors:  K T Pitman; P D Costantino; L F Lassen
Journal:  Skull Base Surg       Date:  1995

Review 4.  Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system.

Authors:  Rami E Saade; Ehab Y Hanna; Diana Bell
Journal:  Curr Oncol Rep       Date:  2015-01       Impact factor: 5.075

5.  Incidence and survival patterns of sinonasal undifferentiated carcinoma in the United States.

Authors:  Kyle J Chambers; Ashton E Lehmann; Aaron Remenschneider; Matthew Dedmon; Josh Meier; Stacey T Gray; Derrick T Lin
Journal:  J Neurol Surg B Skull Base       Date:  2014-09-29

6.  Composite enteric-type adenocarcinoma-carcinoid of the nasal mucosa.

Authors:  Marzia Bonato; Bruno Frigerio; Carlo Capelia; Anna Maria Chiaravalli; Michele Cerati
Journal:  Endocr Pathol       Date:  1993-03       Impact factor: 3.943

7.  Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases.

Authors:  Aatur D Singhi; Raja R Seethala; Katie Nason; Tyler J Foxwell; Robyn L Roche; Kevin M McGrath; Ryan M Levy; James D Luketich; Jon M Davison
Journal:  Hum Pathol       Date:  2014-12-17       Impact factor: 3.466

8.  Sinonasal Undifferentiated Carcinoma: A 15-Year Single Institution Experience.

Authors:  Alan D Workman; Robert M Brody; Edward C Kuan; Esther Baranov; Steven G Brooks; Michelle Alonso-Basanta; Jason G Newman; Christopher H Rassekh; Ara A Chalian; Alexander G Chiu; Gregory S Weinstein; Michael D Feldman; Nithin D Adappa; Bert W O'Malley; James N Palmer
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-16

9.  Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma.

Authors:  Yoko Takahashi; Michael E Kupferman; Diana Bell; Tilahun Jiffar; June Goo Lee; Tong-Xin Xie; Ning-Wei Li; Mei Zhao; Mitchell J Frederick; Alexander Gelbard; Jeffrey N Myers; Ehab Y Hanna
Journal:  Clin Cancer Res       Date:  2012-10-02       Impact factor: 12.531

Review 10.  [Sinonasal tumors : News from the WHO with special reference to mesenchymal entities].

Authors:  A Agaimy; F Haller; A Hartmann
Journal:  Pathologe       Date:  2018-02       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.